2 Green Flags for Abbott Laboratories' Future
The past year hasn't been the best for Abbott Laboratories (NYSE: ABT) and its shareholders, as the medical devices giant has lagged the broader market. But zooming out helps give some perspective: The company has soundly outperformed the broader market over the last five, 10, and 20 years.
There are excellent reasons to think Abbott will produce more market-beating returns in the years to come for investors willing to be patient. Here are just two reasons the future is bright for this medical devices company.
Source Fool.com